REGN

Regeneron Pharmaceuticals, Inc. (REGN)

Last Price$700.30.6%
Market Cap$75.4B
DCF value
$1,274.5
Undervalued (DCF value)
82.0%
Discount Rate
7.4%
Long-Term Growth Rate
3.0%
Stock quality
7/10
Good

REGN DCF Model

Crunching data... Almost there!

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

REGN DCF Value

Crunching data... Almost there!

REGN DCF Financials

Crunching data... Almost there!

REGN DCF sensitivity

Crunching data... Almost there!

Explore more intrinsic value tools hub for REGN

FAQ

What is Regeneron Pharmaceuticals, Inc. DCF (discounted cash flow) valuation?

As of Feb 21, 2025, Regeneron Pharmaceuticals, Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at $1,274.5. This suggests it may be undervalued by 82.0% compared to its current price of around $700.3, using a WACC of 7.4% and growth rates of 3.0%.

What is Regeneron Pharmaceuticals, Inc. WACC?

As of Feb 21, 2025, Regeneron Pharmaceuticals, Inc.'s Weighted Average Cost of Capital (WACC) is approximately 7.4%.

What is Regeneron Pharmaceuticals, Inc. Enterprise Value?

As of Feb 21, 2025, Regeneron Pharmaceuticals, Inc.'s Enterprise Value (EV) is approximately $130.8B. This value reflects the company's total market capitalization plus debt, minus cash and cash equivalents, providing a comprehensive measure of its overall value in the market.